C30-C39 J09-J18 J30-J39 J40-J47 J60-J70 J80-J84 J85-J86 J90-J94
Conditions
Interventions
Group 1: This study is aimed at patients with lung diseases, including common lung diseases such as asthma or COPD, malignant lung diseases and rarer lung diseases such as pulmonary fibrosis and pulmo
Sponsors
Medizinische Klinik und Poliklinik V, LMU Klinikum der Universität München
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: In order to be able to research as wide a variety of lung diseases and disease stages as possible, all patients who are treated and/or operated on as outpatients in the thoracic surgery, pneumology outpatient clinic, research outpatient clinic or in the Asklepios Fachkliniken München-Gauting are asked for their consent. This includes patients who are undergoing lung transplantation in the Thoracic Surgery Department. The indication for a patient's treatment is based solely on clinical criteria and is independent of the patient's willingness to provide biomaterials or clinical data. Included are all patients with chronic lung disease especially patients with interstitial (ILDs), obstructive (COPD and asthma) and vascular lung disease, patients before and after lung transplantation as well as patients with COVID-19 infection and patients with tumorous lung disease.
Exclusion criteria
Exclusion criteria: Patients with active hepatitis B or C, HIV, confirmed or clinically and/or radiologically probable tuberculosis, patients without valid informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No primary endpoint is planned for this study. As this is a bioarchive with clinical data and biological material samples (blood, cells, tissue, urine, BAL, etc.), no primary endpoint is to be defined. Only when a scientist submits an application and wishes to use biosamples and/or data from the bioarchive will a specific study protocol with defined target variables be drawn up. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome is considered for this study. | — |
Countries
Germany
Contacts
Public ContactAnja Disovic
Comprehensive Pneumology Center (CPC)Ludwig-Maximilians-Universität, Asklepios Fachkliniken München-Gauting und Helmholtz Zentrum München
Outcome results
None listed